Cardiac magnetic resonance imaging perfusion

Cardiac magnetic resonance imaging perfusion (cardiac MRI perfusion, CMRI perfusion), also known as stress CMR perfusion,[1] is a clinical magnetic resonance imaging test performed on patients with known or suspected coronary artery disease to determine if there are perfusion defects in the myocardium of the left ventricle that are caused by narrowing of one or more of the coronary arteries.

Cardiac magnetic resonance imaging perfusion
Contrast appears in the right ventricle then left ventricle before blushing into the muscle, which is normal (top) and abnormal (bottom, an inferior perfusion defect)
SynonymsStress CMR perfusion
Purposetest performed on patients with known or suspected coronary artery disease

Introduction

edit

CMR perfusion is increasingly used in cardiac imaging to test for inducible myocardial ischaemia and has been well validated against other imaging modalities such as invasive angiography[2][3] or FFR. Several recent large-scale studies have shown non-inferiority or superiority to SPECT imaging. It is becoming increasingly established as a marker of prognosis in patients with coronary artery disease.[4][5]

Indications

edit

Mechanism

edit

Image analysis

edit

The images are stored as video files and are analysed on a dedicated workstation. The majority of clinical scans are analysed qualitatively by visually comparing the stress and rest scans in parallel. In a normal scan, the wash in (1st pass) of gadolinium into the myocardium can be seen as the myocardium turning from black to mid grey uniformly throughout the whole of the left ventricle in both the stress and rest scans. In an abnormal scan an area of the myocardium will turn grey slower than the surrounding tissue as the blood (and hence gadolinium) enters more slowly due to a narrowing of the coronary artery supplying it. This is called a perfusion defect and usually represents myocardial ischaemia. It may be seen on both the rest and stress scans in which case it is called a matched perfusion defect and is probably due to an area or scar from a previous myocardial infarction. If it is only seen on the stress scan it is called an area of inducible perfusion defect (ischaemia). The position in the left ventricle of the perfusion defects are described using the AHA 17 segment model.[6]

Limitations

edit

Safety

edit

References

edit
  1. ^ Rieber, J. (2005). "Cardiac magnetic resonance perfusion imaging for the functional assessment of coronary artery disease: a comparison with coronary angiography and fractional flow reserve". European Heart Journal. 27 (12): 1465–1471. doi:10.1093/eurheartj/ehl039. ISSN 0195-668X. PMID 16720685.
  2. ^ Wilke NM, Jerosch-Herold M, Zenovich A, Stillman AE (1999). "Magnetic resonance first-pass myocardial perfusion imaging: clinical validation and future applications". J Magn Reson Imaging. 10 (5): 676–85. doi:10.1002/(sici)1522-2586(199911)10:5<676::aid-jmri10>3.0.co;2-l. PMID 10548775. S2CID 45920843.
  3. ^ Al-Saadi N, Nagel E, Gross M, et al. (2000). "Noninvasive detection of myocardial ischemia from perfusion reserve based on cardiovascular magnetic resonance". Circulation. 101 (12): 1379–83. doi:10.1161/01.cir.101.12.1379. PMID 10736280.
  4. ^ Jahnke C, Nagel E, Gebker R, et al. (2007). "Prognostic value of cardiac magnetic resonance stress tests: adenosine stress perfusion and dobutamine stress wall motion imaging". Circulation. 115 (13): 1769–76. doi:10.1161/CIRCULATIONAHA.106.652016. PMID 17353441.
  5. ^ Schwitter J, Wacker CM, van Rossum AC, et al. (2008). "MR-IMPACT: comparison of perfusion-cardiac magnetic resonance with single-photon emission computed tomography for the detection of coronary artery disease in a multicentre, multivendor, randomized trial". European Heart Journal. 29 (12): 480–89. doi:10.1093/eurheartj/ehm617. PMID 18208849.
  6. ^ Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, Pennell DJ, Rumberger JA, Ryan T, Verani MS (2002). "Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association". Circulation. 105 (4): 539–42. doi:10.1161/hc0402.102975. PMID 11815441.